Blackrock Inc vs BioNTech SE - ADR — how do they compare? Blackrock Inc trades at $1,145.5 (market cap $177.92B), while BioNTech SE - ADR trades at $92.8 (market cap $23.31B). The key difference: Blackrock Inc is far larger — about 7.6× BioNTech SE - ADR's market cap, and Blackrock Inc pays a 2% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BLK | BNTX | |
|---|---|---|
Market Cap | $177.92B | $23.31B |
Volume | 641,547 | — |
Sector | Financials | Health |
52-Week High | $1.20K | $119.34 |
52-Week Low | $922.90 | $83.89 |
Enterprise Value | $179.02B | $6.60B |
Dividend Yield | 2% | — |
Trailing returns across standard periods
Latest headlines on both assets
BlackRock, Inc. provides investment management services to institutional clients and to retail investors through various investment vehicles. The Company manages funds, as well as offers risk management services. BlackRock serves governments, companies, and foundations worldwide.
Read more on BLK →BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →